Literature DB >> 9414089

The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain.

K L Borden1, E J CampbellDwyer, M S Salvato.   

Abstract

The promyelocytic leukemia protein PML is known to form nuclear multiprotein complexes which are compromised in several pathogenic conditions including acute promyelocytic leukemia. We show that in cells infected with a single stranded RNA virus, which relocates PML bodies to the cytoplasm, the infected cells are more resistant to serum starvation induced apoptosis than their uninfected counterparts. Antisense PML oligonucleotides increase cell survival under serum deprivation conditions indicating that PML is directly involved in the apoptotic activity. Transient transfection studies have indicated that this pro-apoptotic activity of PML is mediated through the zinc binding region known as the RING finger. Viral attack of PML nuclear bodies appears to allow the virus to deregulate host cell apoptotic machinery in order to establish chronic infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9414089      PMCID: PMC2398725          DOI: 10.1016/s0014-5793(97)01344-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

Review 1.  Social controls on cell survival and cell death.

Authors:  M C Raff
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

2.  Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia.

Authors:  A D Goddard; J Borrow; P S Freemont; E Solomon
Journal:  Science       Date:  1991-11-29       Impact factor: 47.728

3.  The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0.

Authors:  G G Maul; R D Everett
Journal:  J Gen Virol       Date:  1994-06       Impact factor: 3.891

4.  A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein.

Authors:  J A Dyck; G G Maul; W H Miller; J D Chen; A Kakizuka; R M Evans
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 5.  Apoptosis in the pathogenesis and treatment of disease.

Authors:  C B Thompson
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

6.  Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells.

Authors:  K Weis; S Rambaud; C Lavau; J Jansen; T Carvalho; M Carmo-Fonseca; A Lamond; A Dejean
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

7.  Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA.

Authors:  M D Jacobson; J F Burne; M P King; T Miyashita; J C Reed; M C Raff
Journal:  Nature       Date:  1993-01-28       Impact factor: 49.962

8.  PML nuclear bodies are general targets for inflammation and cell proliferation.

Authors:  B Terris; V Baldin; S Dubois; C Degott; J F Flejou; D Hénin; A Dejean
Journal:  Cancer Res       Date:  1995-04-01       Impact factor: 12.701

9.  A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies.

Authors:  N Stuurman; A de Graaf; A Floore; A Josso; B Humbel; L de Jong; R van Driel
Journal:  J Cell Sci       Date:  1992-04       Impact factor: 5.285

10.  The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.

Authors:  M H Koken; F Puvion-Dutilleul; M C Guillemin; A Viron; G Linares-Cruz; N Stuurman; L de Jong; C Szostecki; F Calvo; C Chomienne
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

View more
  26 in total

1.  RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome.

Authors:  T I Cornu; J C de la Torre
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Authors:  Ki Jeong Lee; Mar Perez; Daniel D Pinschewer; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis.

Authors:  Tatjana I Cornu; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Cells expressing the RING finger Z protein are resistant to arenavirus infection.

Authors:  Tatjana I Cornu; Heinz Feldmann; Juan Carlos de la Torre
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner.

Authors:  E J Campbell Dwyer; H Lai; R C MacDonald; M S Salvato; K L Borden
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected].

Authors:  Thomas Strecker; Robert Eichler; Jan ter Meulen; Winfried Weissenhorn; Hans Dieter Klenk; Wolfgang Garten; Oliver Lenz
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.

Authors:  Ivan Topisirovic; Allan D Capili; Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  Expression of promyelocytic leukemia protein increases during the differentiation of human neuroblastoma cells.

Authors:  Eunsil Yu; Eun Kyung Choi; Chong Jai Kim
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

9.  Daxx silencing sensitizes cells to multiple apoptotic pathways.

Authors:  Liuh-Yow Chen; J Don Chen
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase.

Authors:  G W Carlile; W G Tatton; K L Borden
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.